These are glimpses into the work we do, the things we care about, and the milestones we’re working towards.

Well positioned for success: strong q3 results; top-tier growth through 2020

See AbbVie’s strong performance in Q3, with results well ahead of expectations, and the company’s long-term strategic and financial objectives, which provide guidance for total company sales of approximately $37 billion dollars in 2020.  

Second Quarter 2015 Financial Results

Our strong portfolio drove revenue growth in Q2 with adjusted EPS up 31.7 percent, while our strategic acquisition of Pharmacyclics and robust development pipeline position AbbVie well for the future.